Literature DB >> 27974162

Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

Sarah K Kaufman1, David W Sanders1, Talitha L Thomas2, Allison J Ruchinskas2, Jaime Vaquer-Alicea2, Apurwa M Sharma3, Timothy M Miller4, Marc I Diamond5.   

Abstract

Tauopathies are neurodegenerative disorders that affect distinct brain regions, progress at different rates, and exhibit specific patterns of tau accumulation. The source of this diversity is unknown. We previously characterized two tau strains that stably maintain unique conformations in vitro and in vivo, but did not determine the relationship of each strain to parameters that discriminate between tauopathies such as regional vulnerability or rate of spread. We have now isolated and characterized 18 tau strains in cells based on detailed biochemical and biological criteria. Inoculation of PS19 transgenic tau (P301S) mice with these strains causes strain-specific intracellular pathology in distinct cell types and brain regions, and induces different rates of network propagation. In this system, strains alone are sufficient to account for diverse neuropathological presentations, similar to those that define human tauopathies. Further study of these strains can thus establish a structural logic that governs these biological effects.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cell model; prion; prion-like; seeding activity; strain; tau; tau pathology; tauopathy; transcellular propagation

Mesh:

Substances:

Year:  2016        PMID: 27974162      PMCID: PMC5392364          DOI: 10.1016/j.neuron.2016.09.055

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  38 in total

1.  Alzheimer's disease: rapid and slow progression.

Authors:  Craig J Thalhauser; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2011-06-08       Impact factor: 4.118

2.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.

Authors:  W Peelaerts; L Bousset; A Van der Perren; A Moskalyuk; R Pulizzi; M Giugliano; C Van den Haute; R Melki; V Baekelandt
Journal:  Nature       Date:  2015-06-10       Impact factor: 49.962

3.  A network diffusion model of disease progression in dementia.

Authors:  Ashish Raj; Amy Kuceyeski; Michael Weiner
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

4.  Predicting regional neurodegeneration from the healthy brain functional connectome.

Authors:  Juan Zhou; Efstathios D Gennatas; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

5.  Human prion strain selection in transgenic mice.

Authors:  Kurt Giles; David V Glidden; Smita Patel; Carsten Korth; Darlene Groth; Azucena Lemus; Stephen J DeArmond; Stanley B Prusiner
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

6.  Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Authors:  Michiyo Iba; Jing L Guo; Jennifer D McBride; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

7.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

8.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

10.  Structural and functional characterization of two alpha-synuclein strains.

Authors:  Luc Bousset; Laura Pieri; Gemma Ruiz-Arlandis; Julia Gath; Poul Henning Jensen; Birgit Habenstein; Karine Madiona; Vincent Olieric; Anja Böckmann; Beat H Meier; Ronald Melki
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  159 in total

1.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

2.  Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Authors:  Anan Yu; Susan G Fox; Annalisa Cavallini; Caroline Kerridge; Michael J O'Neill; Joanna Wolak; Suchira Bose; Richard I Morimoto
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

3.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

4.  Cofactors are essential constituents of stable and seeding-active tau fibrils.

Authors:  Yann Fichou; Yanxian Lin; Jennifer N Rauch; Michael Vigers; Zhikai Zeng; Madhur Srivastava; Timothy J Keller; Jack H Freed; Kenneth S Kosik; Songi Han
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-11       Impact factor: 11.205

5.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

6.  Neurodegenerative disease: Straining the brain.

Authors:  Darran Yates
Journal:  Nat Rev Neurosci       Date:  2016-11-17       Impact factor: 34.870

7.  Neurodegenerative disease: New in vivo evidence that different tau strains cause different diseases.

Authors:  Ian Fyfe
Journal:  Nat Rev Neurol       Date:  2016-11-11       Impact factor: 42.937

8.  Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.

Authors:  Romany Abskharon; Paul M Seidler; Michael R Sawaya; Duilio Cascio; Tianxiao P Yang; Stephan Philipp; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; Philip L Felgner; Rie Nakajima; Charles G Glabe; David S Eisenberg
Journal:  J Biol Chem       Date:  2020-06-03       Impact factor: 5.157

9.  Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus α-synuclein and β-amyloid aggregates.

Authors:  Barbara E Stopschinski; Brandon B Holmes; Gregory M Miller; Victor A Manon; Jaime Vaquer-Alicea; William L Prueitt; Linda C Hsieh-Wilson; Marc I Diamond
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

10.  Evidence of corticofugal tau spreading in patients with frontotemporal dementia.

Authors:  Eun-Joo Kim; Ji-Hye L Hwang; Stephanie E Gaus; Alissa L Nana; Jersey Deng; Jesse A Brown; Salvatore Spina; Myung Jun Lee; Eliana Marisa Ramos; Lea T Grinberg; Joel H Kramer; Adam L Boxer; Maria Luisa Gorno-Tempini; Howard J Rosen; Bruce L Miller; William W Seeley
Journal:  Acta Neuropathol       Date:  2019-09-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.